This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2017 Sep 19;318(11):1061-1062.

doi: 10.1001/jama.2017.10593.

Urine Drug Screens to Monitor Opioid Use for Managing Chronic Pain

Shannon Haymond¹, Geeta Nagpal², Heather Heiman³

Affiliations

Affiliations

¹ Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
² Department of Anesthesia, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
³ Departments of Medicine and Medical Education, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

PMID: 28975284
DOI: 10.1001/jama.2017.10593

Case Reports

Urine Drug Screens to Monitor Opioid Use for Managing Chronic Pain

Shannon Haymond et al. JAMA. 2017.

. 2017 Sep 19;318(11):1061-1062.

doi: 10.1001/jama.2017.10593.

Authors

Shannon Haymond¹, Geeta Nagpal², Heather Heiman³

Affiliations

¹ Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
² Department of Anesthesia, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
³ Departments of Medicine and Medical Education, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

PMID: 28975284
DOI: 10.1001/jama.2017.10593

No abstract available

PubMed Disclaimer

Similar articles

How to set boundaries with chronic pain patients.
Cosio D. Cosio D. J Fam Pract. 2014 Mar;63(3 Suppl):S3-8. J Fam Pract. 2014. PMID: 24701609 Review.
A leader in the field...
DeVito RA Jr. DeVito RA Jr. J Opioid Manag. 2015 Jan-Feb;11(1):6. J Opioid Manag. 2015. PMID: 25881374 No abstract available.
Sensitivity of an opiate immunoassay for detecting hydrocodone and hydromorphone in urine from a clinical population: analysis of subthreshold results.
Bertholf RL, Johannsen LM, Reisfield GM. Bertholf RL, et al. J Anal Toxicol. 2015 Jan-Feb;39(1):24-8. doi: 10.1093/jat/bku109. Epub 2014 Oct 6. J Anal Toxicol. 2015. PMID: 25288720
Immunoassay in healthcare testing applications.
DePriest AZ, Black DL, Robert TA. DePriest AZ, et al. J Opioid Manag. 2015 Jan-Feb;11(1):13-25. doi: 10.5055/jom.2015.0248. J Opioid Manag. 2015. PMID: 25750161 Review.
Six-month, open-label study of hydrocodone extended release formulated with abuse-deterrence technology: Safety, maintenance of analgesia, and abuse potential.
Hale ME, Ma Y, Malamut R. Hale ME, et al. J Opioid Manag. 2016 May-Jun;12(2):139-47. doi: 10.5055/jom.2016.0326. J Opioid Manag. 2016. PMID: 27194199 Clinical Trial.

See all similar articles

Cited by

Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified.
Wyse JJ, Morasco BJ, Dobscha SK, Demidenko MI, Meath THA, Lovejoy TI. Wyse JJ, et al. J Opioid Manag. 2018 Jul/Aug;14(4):295-303. doi: 10.5055/jom.2018.0461. J Opioid Manag. 2018. PMID: 30234926 Free PMC article.
The Opioid Epidemic and Pain Medicine Specialists: Where to Begin and What Is Next?
Tolba R, Meselhy E, Guerra CE. Tolba R, et al. Ochsner J. 2018 Spring;18(1):20-22. Ochsner J. 2018. PMID: 29559864 Free PMC article. No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information